INVO Fertility stock analysis
Want to see IVF full AI Analyst Report?
INVO Fertility (IVF) Stock Price & Analysis
IVF Stock Chart & Stats
- Day’s Range
- $2.60 - $2.77
- 52-Week Range
- $1.59 - $91.60
- Previous Close
- $2.69
- Volume
- N/A
- Average Volume (3M)
- 32.64K
- Market Cap
- $3.10M
- Enterprise Value
- $5.51M
- Total Cash (Recent Filing)
- $3.73M
- Total Debt (Recent Filing)
- $3.92M
- Price to Earnings (P/E)
- ―
- Beta
- 0.31
- Next Earnings
- Nov 23, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth
Revenue expansion from approximately $0.8 million in 2022 to $7.5 million TTM indicates substantial commercial traction in fertility services. If this growth continues, greater patient and treatment volume could improve operating leverage and provide a broader base for future profitability.
Positive Gross Margin
A positive, relatively stable gross margin shows that fertility services generate contribution after direct costs, even though corporate expenses currently exceed gross profit. This provides an economic foundation for scaling the business and potentially narrowing losses as revenue grows.
Improved Balance Sheet
The move to approximately 0.27 debt-to-equity from highly stressed prior levels materially improves financial resilience. A larger equity base provides a better buffer for ongoing losses and gives management more flexibility to fund operations while pursuing growth in fertility services.
Bears Say
Persistent Unprofitability
Despite meaningful revenue growth and positive gross margin, the company remains structurally unprofitable, with operating and net margins deeply negative across the periods provided. Continued losses indicate that scale has not yet translated into a self-sustaining earnings model.
Ongoing Cash Burn
Sustained negative operating and free cash flow means the business is consuming cash to operate and invest rather than internally funding expansion. Persistent burn increases dependence on outside capital and could constrain growth or strategic flexibility if financing conditions become less favorable.
Equity Financing And Dilution
The financing improves near-term liquidity and supports continued operations, but relying on equity capital can dilute existing shareholders and signal that internal cash generation is insufficient. Further draws under the larger commitment could increase dilution while losses and cash needs persist.
INVO Fertility News
IVF FAQ
What was INVO Fertility’s price range in the past 12 months?
What is INVO Fertility’s market cap?
When is INVO Fertility’s upcoming earnings report date?
How were INVO Fertility’s earnings last quarter?
Is INVO Fertility overvalued?
Does INVO Fertility pay dividends?
What is INVO Fertility’s EPS estimate?
How many shares outstanding does INVO Fertility have?
What happened to INVO Fertility’s price movement after its last earnings report?
Which hedge fund is a major shareholder of INVO Fertility?
What is the TipRanks Smart Score and how is it calculated?
Company Description
INVO Fertility
INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Steven Shum
- Employees
- 41
- Website
- www.invofertility.com
- Address
- 5582 Broadcast Court, Sarasota, FL, 34240, US
INVO Fertility (IVF) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 8 | 3 | 11 |
| Technical Analysis | 2 | 3 | 5 |
| Moving Averages | 6 | 0 | 6 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| NIVFNewGenIvf Group |














